New blood test could spot deadly infection risk in vulnerable cancer patients

NCT ID NCT07277387

Summary

This study aims to find new patterns in blood proteins that can predict which cancer patients with low white blood cell counts and fever are most likely to develop serious complications like sepsis. Researchers will analyze blood samples from 350 adult patients with blood cancers who develop fever during treatment. By comparing protein patterns in patients who do and do not develop complications, they hope to create a better prediction tool than current tests.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FEBRILE NEUTROPENIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Complejo Asistencial Universitario de Salamanca

    Salamanca, Salamanca, 37007, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hospital Universitari Vall d'Hebron

    Barcelona, Barcelona, Spain

  • Hospital Universitario Virgen Macarena

    Seville, Sevilla, Spain

Conditions

Explore the condition pages connected to this study.